Neurological Disorders

Diagnostic laboratory joint venture expands RNA sequencing at Baylor

By LabPulse.com staff writers

WT RNAseq goes beyond the interpretation of already identified variants by whole exome sequencing (WES) or whole genome sequencing (WGS), according to Baylor Genetics.

August 6, 2024

Researchers develop sensitive blood test for gene expression in the brain

By Nick Paul Taylor

Analysis of molecules that travel from the brain into blood could enable noninvasive monitoring of gene expression in the organ, according to research published in Nature Biotechnology.

January 19, 2024

AI neuroimaging model aims to predict neuropathic pain treatment responses

By Matt Limb

A magnetic resonance (MR) neuroimaging model which uses artificial intelligence (AI) to identify new biomarkers could lead to more effective medical treatment for chronic nerve pain, say the researchers developing the model.

August 25, 2023

Blood test detects neurometabolic disease to simplify, accelerate diagnosis

By Nick Paul Taylor

A study compared a blood test METAglut1, which quantifies GLUT1 on the surface of red blood cells, to glycorrhachia measured via lumbar puncture in a prospective cohort of 428 patients and a retrospective cohort of 67 patients.

June 6, 2023

Serum assay may enable the diagnosis of neurodegenerative diseases

By Elissa Wolfson

An assay that detects minute concentrations of alpha synuclein seeds in blood serum may enable quicker diagnosis of neurodegenerative disorders.

May 30, 2023

A closer look at long COVID symptoms

By Elissa Wolfson

Intensively studied patients with persistent post-COVID neurological symptoms were found to have autonomic dysfunction and differences in their immune cell profiles.

May 10, 2023

Indiana University, MindX Sciences researchers developing blood test for anxiety

By Elissa Wolfson

A blood test for anxiety may determine an individual’s risk of developing anxiety, and which therapies might treat it most effectively, the researchers said.

March 8, 2023

Study supports genetic testing for people with cerebral palsy

By Elissa Wolfson

A meta-analysis of recent cerebral palsy research suggests that genetic testing could be offered as the standard procedure for people with the disorder.

March 7, 2023

Quanterix Q4 revenues drop 15% but match analysts’ expectations

By Leo O'Connor

For full-year 2022, total revenue was $105.5 million, a decline of 5% compared with 2021 revenue that included $5.2 million in National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) grant money.

March 6, 2023

Invitae announces data on epilepsy genetic testing outcomes

By LabPulse.com staff writers

Among patients whose treatment was changed based on genetic testing, 75% reported positive health outcomes, including 65% who saw a reduction in frequency -- even elimination -- of seizures.

November 1, 2022

Variantyx obtains $20M in funding

By LabPulse.com staff writers

Whole genome sequencing tracks changes in genes that can cause disease. Variantyx is developing the testing method for the diagnosis of rare inherited and neurological disorders, it said.

March 15, 2021

Researchers outline neurological signs of COVID-19

By Kate Madden Yee

The neurological complications of COVID-19 are becoming more obvious as the pandemic wears on, and they consist of a startling range of conditions, according to a team led by Ross Paterson, PhD, of University College London.

July 8, 2020

Page 1 of 2

Next Page